On Friday, Cassava Sciences Inc (NASDAQ: SAVA) opened higher 6.35% from the last session, before settling in for the closing price of $25.34. Price fluctuations for SAVA have ranged from $8.79 to $42.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 72.84% at the time writing. With a float of $41.77 million, this company’s outstanding shares have now reached $42.24 million.
Let’s look at the performance matrix of the company that is accounted for 29 employees. In terms of profitability, gross margin is 58.82%, operating margin of -5871.72%, and the pretax margin is -752.3%.
Cassava Sciences Inc (SAVA) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cassava Sciences Inc is 11.66%, while institutional ownership is 28.23%.
Cassava Sciences Inc (SAVA) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.5 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.52) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 72.84% per share during the next fiscal year.
Cassava Sciences Inc (NASDAQ: SAVA) Trading Performance Indicators
Check out the current performance indicators for Cassava Sciences Inc (SAVA). In the past quarter, the stock posted a quick ratio of 3.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.37, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -0.65 in one year’s time.
Technical Analysis of Cassava Sciences Inc (SAVA)
Cassava Sciences Inc (NASDAQ: SAVA) saw its 5-day average volume 1.71 million, a positive change from its year-to-date volume of 1.71 million. As of the previous 9 days, the stock’s Stochastic %D was 65.27%. Additionally, its Average True Range was 1.94.
During the past 100 days, Cassava Sciences Inc’s (SAVA) raw stochastic average was set at 54.35%, which indicates a significant decrease from 63.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.59% in the past 14 days, which was lower than the 148.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.72, while its 200-day Moving Average is $22.81. Nevertheless, the first resistance level for the watch stands at $28.37 in the near term. At $29.79, the stock is likely to face the second major resistance level. The third major resistance level sits at $31.60. If the price goes on to break the first support level at $25.14, it is likely to go to the next support level at $23.33. Assuming the price breaks the second support level, the third support level stands at $21.91.
Cassava Sciences Inc (NASDAQ: SAVA) Key Stats
There are currently 47,976K shares outstanding in the company with a market cap of 1.38 billion. Presently, the company’s annual sales total 0 K according to its annual income of -97,220 K. Last quarter, the company’s sales amounted to 0 K and its income totaled 6,160 K.
